Brown Advisory’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.8M Buy
445,558
+115,994
+35% +$12.6M 0.1% 148
2026
Q1
$30.4M Buy
+329,564
New +$33.1M 0.05% 260
2021
Q2
Sell
-1,639
Closed -$250K 1098
2021
Q1
$250K Buy
+1,639
New +$248K ﹤0.01% 985

Other funds holding GH

Brown Advisory's GH Position: Q2 2026 in Review

Brown Advisory increased its Guardant Health (GH) stake by 35% in Q2 2026, buying an estimated $12.6M and bringing the position to 445,558 shares worth $66.8M. The position accounts for 0.1% of the portfolio, ranked #148.

Brown Advisory first reported a position in GH in Q1 2021 and has held it in 3 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Brown Advisory held 445,558 shares of Guardant Health worth $66.8M as of Q2 2026.
  • Brown Advisory bought 115,994 Guardant Health shares in Q2 2026, an estimated $12.6M.
  • Guardant Health made up 0.1% of Brown Advisory's portfolio in Q2 2026, its #148 holding.
  • Brown Advisory first reported a position in Guardant Health in Q1 2021 and has held it in 3 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.